Jeanine M. Walenga

Papers

Total Citations

H-Index

About

Jeanine M. Walenga is a leading authority in cardiovascular pharmacology and hemostasis, with a career dedicated to advancing the understanding and clinical management of thrombosis. Her seminal work has focused on the development and clinical application of anticoagulants, particularly low-molecular-weight heparins and the synthetic pentasaccharide fondaparinux, which have revolutionized the prevention and treatment of venous thromboembolism. Walenga’s research has been instrumental in elucidating the mechanisms of action of these agents and establishing their safety and efficacy profiles, with her highly cited studies collectively garnering thousands of citations. She has also made significant contributions to the field of cardiopulmonary bypass, exploring the inflammatory and coagulative responses during surgery. Notably, her recent work has expanded into comparative surgical outcomes, such as the cytokine response in robot-assisted versus video-assisted thoracic surgery. A prolific author and editor, Walenga has served as a key figure in shaping clinical guidelines and laboratory monitoring standards for anticoagulant therapy, making her an indispensable resource for clinicians and researchers alike.